HighTower Advisors
EDVA

HighTower Advisors’s Endovia Health Sciences, Inc. EDVA Stock Holding History

HighTower Advisors’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,438
Closed -$253K – 3879
2024
Q1 		$253K Buy
+3,438
New +$274K ﹤0.01% 2810

Other funds holding EDVA

CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SCTC
Sanibel Captiva Trust Company Sanibel, Florida $4.02B AUM 34.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HighTower Advisors's EDVA Position: Q2 2024 in Review

HighTower Advisors sold out of Endovia Health Sciences, Inc. (EDVA) in Q2 2024, closing a stake of 3,438 shares — an estimated $253K sold.

HighTower Advisors first reported a position in EDVA in Q1 2024 and held it in 1 quarter. The position peaked at $253K in Q1 2024. 31 funds tracked by Wall St. Rank hold EDVA as of Q2 2024.

  • HighTower Advisors reported no remaining Endovia Health Sciences, Inc. position as of Q2 2024 after selling out during the quarter.
  • HighTower Advisors sold 3,438 Endovia Health Sciences, Inc. shares in Q2 2024, an estimated $253K.
  • HighTower Advisors first reported a position in Endovia Health Sciences, Inc. in Q1 2024 and held it in 1 quarter.
  • HighTower Advisors's Endovia Health Sciences, Inc. position peaked at $253K in Q1 2024.
  • 31 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q2 2024.

Based on HighTower Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.